The Polish Pharmacoeconomics Society (ISPOR Poland Chapter) held the XV Annual International Conference on 30 November -1 December 2017 in the Hotel Airport Okecie, Warsaw, Poland.
ISPOR Poland Chapter organized the 15th International Conference on 30 November-1 December 2017 in Warsaw, Poland. Dr. Maciej Niewada, President of the Polish Pharmacoeconomics Society (ISPOR Poland Chapter), Dr. Joanna Lis, Past President; Prof. Marcin Czech, Under Secretary of State at the Polish Ministry of Health ), delivered a warm welcome to the attendees of the conference.
The main topic of the conference Drug Pricing in Europe – Fair, Uniform or Both? has been presented by Dr. Zoltan Kalo (Hungary) on Thursday, November 30.
A panel discussion on rational medicinal policy in CEE countries followed the topic and has been moderated by Dr. Maciej Niewada. Many experts from European countries have participated as speakers at the event: Dr. Jiri Samek (Czech Republic), Prof. John Yfantopoulos (Greece) and Prof. Tomas Tesar (Slovakia).
Afternoon session was devoted to the situation of HTA in Poland with presentations of the Polish Agency for Health Technology Assessment representatives.
Second day of the conference, Friday, 1 December, has been dedicated to the session on medical devices, followed by session of RWE, Polish EQ-5D-5L valuation study and HTA in oncology and in hospital setting.
Afternoon session involved student presentations of original studies.
The conference focused on the topic of investing in coordinated care and featured presentations by regional and international experts. The Polish Deputy Minister of Health, Dr. Krzysztof Łanda spoke about the new possibilities for reimbursement of medical devices, amendments in reimbursement act and changes planned in health policies in Poland. ISPOR President, Prof. Lou Garrison, delivered a presentation on “The Second U.S. Panel Report on CEA: Key Findings and Implications for HTA,” and Prof. Ben van Hout presented on good economic practice, sensitivity analysis, and medical devices. The ISPOR CEE Network Chair, Vlad Zah and President of ISPOR Greece Chapter, Prof. John Yfantopoulos participated in a session discussing the potential support of e-health system for reimbursement decision-making. The conference was attended by more than 180 participants and was preceded by series of workshops on health technology assessment, risk-sharing schemes, new HTA guidelines and other hot topics related to HTA in the region.
Patients registries are collected data,", presenting recommendations for the role of patient registries functioning in Poland. For questions, please contact:
“Therapeutic and Diagnostic Device Outcomes Research is the first such comprehensive publication available in Polish language, which as a whole deals with the subject of clinical effectiveness assessment and economic efficiency of products used in medical diagnosis and treatment. It provides necessary information for the Polish medical decision makers, payers, health care experts, analysts, clinicians and patients. It is a very important element of Pharmacoeconomic education. We have dealt so far mainly with drugs and now we have a ‘bible’ for medical devices. I am sure that this translation will be welcomed by Polish readers with a high interest and attention.” - Joanna Lis, MSc, PhD, President, ISPOR Poland Chapter.
For more information on all ISPOR books, visit: http://www.ispor.org/publications/BooksIndex.asp
Contact InformationISPOR Poland Regional Chapter Office